Evidence map›Paper›PMID 33661631›Full record

ArticleJournal of natural products2021

Limonoids from

Maria Laura Bellone, Cesar Muñoz Camero, Maria Giovanna Chini, Fabrizio Dal Piaz, Vanessa Hernandez, Giuseppe Bifulco, Nunziatina De Tommasi, Alessandra Braca

Open access · hybridAbstract read
In one paragraph

Article in Journal of natural products, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Insights into the Mechanism of Action of the Degraded Limonoid Prieurianin.International journal of molecular sciences · 2024
    Review
  2. UPLC-ESI/MSFrontiers in chemistry · 2024
    Article
  3. Exploring the Anticancer Potential ofPlants (Basel, Switzerland) · 2023
    Article
  4. Rhanteriol, a NewPlants (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Phytochemistry and Biological Activities ofMolecules (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Maria Laura BelloneDipartimento di Farmacia, Università degli Studi di Salerno, 84084 Fisciano (SA), Italy.
Cesar Muñoz CameroDipartimento di Farmacia, Università di Pisa, 56126 Pisa, Italy.
Maria Giovanna ChiniDipartimento di Bioscienze e Territorio, Università degli Studi del Molise, 86090 Pesche (IS), Italy.
Fabrizio Dal PiazDipartimento di Farmacia, Università degli Studi di Salerno, 84084 Fisciano (SA), Italy.
Vanessa HernandezDepartamento de Farmacognosia y Medicamentos Organicos, Universidad de los Andes, Mérida, 5101, Venezuela.
Giuseppe BifulcoDipartimento di Farmacia, Università degli Studi di Salerno, 84084 Fisciano (SA), Italy.ORCID 0000-0002-1788-5170
Nunziatina De TommasiDipartimento di Farmacia, Università degli Studi di Salerno, 84084 Fisciano (SA), Italy.ORCID 0000-0003-1707-4156
Alessandra BracaDipartimento di Farmacia, Università di Pisa, 56126 Pisa, Italy.ORCID 0000-0002-9838-0448
University of Salerno · ITUniversity of Pisa · ITUniversity of Molise · ITUniversity of the Andes · VE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nine new limonoids (

Indexed as

BenzoxepinsCedrelaHeLa CellsHSP90 Heat-Shock ProteinsHumansLimoninsMeliaceaeMolecular Docking SimulationMolecular StructurePhytochemicalsPlant BarkU937 CellsVenezuelaBenzoxepinsHSP90 Heat-Shock ProteinsLimoninsmexicanolidenomilinPhytochemicals

Identifiers

PMID33661631
PMCPMC8041370
OpenAlexW3134570280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.